Ó£»¨ÊÓÆµ

Skip to main content

Table 3 Multivariate analysis for factors associated with antibiotic under-prescription for diarrheal children under 5 years old with dysentery in Western Kenya, Asembo (n = 123)

From: Inappropriate use of antibiotics for childhood diarrhea case management — Kenya, 2009–2016

Factors

Antibiotic prescribed (%)

Antibiotic not prescribed (%)

Crude odds ratio (95% CI)

Adjustedb odds ratio (95% CI)

Demographics

â€Çã²µ±ð &±ô³Ù; 1

29/90 (32.2%)

12/33 (36.4%)

1.20 (0.52–2.77)

Ìý

 M²¹±ô±ð

50/90 (55.6%)

13/33 (39.4%)

0.52 (0.23–1.17)

Ìý

Recent medical history

 Clinic visit within 14 days

8/90 (8.9%)

3/33 (9.1%)

1.03 (0.26–4.12)

Ìý

 Clinic visit within 14 days with diarrheal symptom

4/90 (4.4%)

1/33 (3.0%)

0.67 (0.07–6.24)

Ìý

 Clinic visit within 14 days with antibiotic treatment

5/90 (5.6%)

0/33 (0%)

N/A

Ìý

Signs and symptoms

 W±ð¾±²µ³ó³Ù-´Ú´Ç°ù-²¹²µ±ð &±ô³Ù; −2

17/89 (19.1%)

9/33 (27.3%)

1.59 (0.63–4.03)

Ìý

‽ö±ð¾±²µ³ó³Ù-´Ú´Ç°ù-²¹²µ±ð &±ô³Ù; −2

22/85 (25.9%)

6/30 (20.0%)

0.72 (0.26–1.98)

Ìý

 W±ð¾±²µ³ó³Ù-´Ú´Ç°ù-³ó±ð¾±²µ³ó³Ù &±ô³Ù; −2

14/85 (16.5%)

5/30 (16.7%)

1.02 (0.33–3.10)

Ìý

 Measured or reported fever

81/90 (90.0%)

31/33 (93.9%)

1.72 (0.35–8.42)

Ìý

 C´Ç³Ü²µ³ó

54/90 (60.0%)

22/33 (66.7%)

1.33 (0.58–3.08)

Ìý

 Difficulty breathing

1 /90 (1.1%)

0/33 (0%)

N/A

Ìý

 Sore throat

1/89 (0.9%)

0/32 (0%)

N/A

Ìý

 V´Ç³¾¾±³Ù¾±²Ô²µ

23/90 (25.6%)

18/33 (54.5%)

3.50 (1.52–8.04)

4.36 (1.98–9.57)

 Runny nose

27/90 (30.0%)

10/33 (30.3%)

1.02 (0.43–2.42)

Ìý

â€ÇȲԱð±ð³ú¾±²Ô²µ

13/90 (14.4%)

6/33 (18.2%)

1.32 (0.46–3.81)

Ìý

Physical examination

 Restless or irritable

7/90 (7.8%)

2/33 (6.1%)

0.77 (0.15–3.88)

Ìý

 Sunken eyes

8/90 (8.9%)

3/33 (12.1%)

1.41 (0.40–5.05)

Ìý

 Drinks eagerly, thirsty

4/90 (4.4%)

1/33 (3.0%)

0.67 (0.07–6.24)

Ìý

 Skin tenting

4/90 (4.4%)

0/33 (0%)

N/A

Ìý

 Signs of anemia

4/88 (4.6%)

0/32 (0%)

N/A

Ìý

 C°ù²¹³¦°ì±ô±ð²õ/°ù²¹±ô±ð²õ

0/90 (0%)

0/33 (0%)

N/A

Ìý

Clinical diagnoses

 G²¹²õ³Ù°ù´Ç±ð²Ô³Ù±ð°ù¾±³Ù¾±²õ

42/90 (45.6%)

10/33 (30.3%)

0.52 (0.22–1.22)

Ìý

 Malaria diagnosis

29/90 (32.2%)

18/33 (54.6%)

2.52 (1.12–5.71)

1.82 (1.05–3.13)

 D±ð³ó²â»å°ù²¹³Ù¾±´Ç²Ô

3/90 (3.3%)

3/33 (9.1%)

2.90 (0.56–15.13)

Ìý

 U¸é°Õ±õa

20/90 (22.2%)

8/33 (24.2%)

1.12 (0.44–2.86)

Ìý

 D²â²õ±ð²Ô³Ù±ð°ù²â

47/90 (52.2%)

8/33 (24.2%)

0.29 (0.12–0.72)

0.30 (0.07–1.24)

Treatment

 Concurrent ORSa

59/90 (65.6%)

14/33 (42.4%)

0.39 (0.17–0.88)

0.34 (0.10–1.19)

 Concurrent zinc

41/90 (45.6%)

15/33 (45.5%)

1.00 (0.45–2.22)

Ìý
  1. aURTI Upper respiratory tract infection, ORS Oral rehydration solution
  2. bAdjusted by variables shown with adjusted OR and within-clinician variation
  3. Odd ratio in bold indicates p-value < 0.05